↓ Skip to main content

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

Overview of attention for article published in Frontiers in oncology, May 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 22,807)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
13 news outlets
twitter
9745 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page
reddit
2 Redditors
video
2 YouTube creators

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report
Published in
Frontiers in oncology, May 2023
DOI 10.3389/fonc.2023.1158124
Pubmed ID
Authors

Sander Eens, Manon Van Hecke, Kasper Favere, Thomas Tousseyn, Pieter-Jan Guns, Tania Roskams, Hein Heidbuchel

X Demographics

X Demographics

The data shown below were collected from the profiles of 9,745 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 9%
Student > Ph. D. Student 1 9%
Unknown 9 82%
Readers by discipline Count As %
Nursing and Health Professions 1 9%
Immunology and Microbiology 1 9%
Medicine and Dentistry 1 9%
Unknown 8 73%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4620. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2024.
All research outputs
#941
of 25,822,778 outputs
Outputs from Frontiers in oncology
#1
of 22,807 outputs
Outputs of similar age
#28
of 411,692 outputs
Outputs of similar age from Frontiers in oncology
#1
of 1,167 outputs
Altmetric has tracked 25,822,778 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,807 research outputs from this source. They receive a mean Attention Score of 3.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 411,692 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1,167 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.